Tiziana Life Sciences
(NASDAQ) TLSA
Tiziana Life Sciences Financials at a Glance
Market Cap
$143.81M
Revenue (TTM)
$0.00
Net Income (TTM)
$31.22M
EPS (TTM)
$-0.11
P/E Ratio
-10.59
Dividend
$0.00
Beta (Volatility)
0.67 (Low)
Dividend
$0.00
Beta (Volatility)
0.67 (Low)
Price
$1.22
Volume
932
Open
$1.27
Price
$1.22
Volume
932
Open
$1.27
Previous Close
$1.22
Daily Range
$1.22 - $1.27
52-Week Range
$0.73 - $2.60
Dividend
$0.00
Beta (Volatility)
0.67 (Low)
Price
$1.22
Volume
932
Open
$1.27
Previous Close
$1.22
Daily Range
$1.22 - $1.27
52-Week Range
$0.73 - $2.60
TLSA News
TLSA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Tiziana Life Sciences
Industry
Biotechnology
Sector
Health CareEmployees
9
CEO
Ivor Elrifi, PhD
Website
www.tizianalifesciences.comHeadquarters
London, W1K 1NA, GB
TLSA Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-232%
Return on Capital
-45%
Return on Assets
-37%
Earnings Yield
-9.44%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$143.81M
Shares Outstanding
118.85M
Volume
932
Short Interest
0.00%
Avg. Volume
200.95K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$15.79M
EBITDA
$16.62M
Operating Cash Flow
$1.22M
Capital Expenditure
$15.18K
Free Cash Flow
$1.23M
Cash & ST Invst.
$3.72M
Total Debt
$106.00K
Tiziana Life Sciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$88.00K
-314.6%
Gross Margin
0.00%
N/A
Market Cap
$143.81M
N/A
Market Cap/Employee
$15.98M
N/A
Employees
9
N/A
Net Income
$5.63M
+34.6%
EBITDA
$5.54M
+35.2%
Quarterly Fundamentals
Net Cash
$7.14M
+14.4%
Accounts Receivable
$4.95M
-42.4%
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$107.00K
-37.1%
Return on Assets
-36.98%
N/A
Return on Invested Capital
-44.82%
N/A
Free Cash Flow
$6.83M
+24.1%
Operating Cash Flow
$6.82M
+24.1%